Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-12-07
1993-06-01
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142315, 5142368, 514252, 514326, 514439, 514445, 514446, 544133, 544145, 544146, 544369, 544374, 546209, 546212, 546213, 548182, 548183, 548186, 548187, 548250, 548253, 549 30, 549 40, 549 62, 549 66, 549 67, A61K 31425, A61K 31535, A61K 21495, A61K 3150, C07D27704, C07D27712, C07D27734, C07D32700, C07D33348, C07D41706
Patent
active
052160025
ABSTRACT:
Provided is a method of treating inflammatory bowel disease in mammals utilizing certain benzyl-substituted rhodanine derivatives. Also provided are novel benzyl-substituted rhodanine derivatives and pharmaceutical compositions thereof, as well as a novel process for selectively isolating in substantially pure enantiomeric form the enantiomers of certain racemic benzyl-substituted rhodanine derivatives.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4376777 (1983-03-01), Kawamatsu et al.
patent: 4387101 (1983-06-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4464382 (1984-08-01), Tanouchi et al.
patent: 4636516 (1987-01-01), Kubo et al.
patent: 5136037 (1992-08-01), Hrib et al.
Patent Abst. of Japan, 11(206), (C-433)[2653](1987), abstracting JP 60-167999.
Patent Abst. of Japan, 11(232), (C-437)[2679](1987), abstracting JP 60-184085.
Gertner et al., Gastroent. J. Club, 2, 3 (1990).
Teuber et al., Liebigs Ann. Chem., 757 (1978).
Patent Abst. of Japan, 5(168), (C-77)[840]1981, abstracting JP 56-97277.
U.S. application Ser. No. 07/604,147, Panetta, Apr. 3, 1990.
Ito et al., Agr. Biol. Chem., 29(8), 728 (1965).
Derwent 87-076383/11 abstracting J6 2029-579-A.
Isomura et al., Chem. Pharm. Bul., 32(1), 152 (1984).
Hidaka et al., Japan J. Pharmacol., 36(77) (1984).
Derwent 84-213508/35, abstracting Australian Patent 8423-287.
Derwent 85-113078/19, abstracting Japanese J6 0054-315-A.
Katsumi et al., Chem. Pharm. Bul., 34(4), 1619 (1986).
Kagan, "Asymmetric Oxidation Mediated by Organometallic Species", Stereochem. Org. Bioorg. Transform. Proc. Workshop Conf. Hoescht, 17, 31 (1986) (Kagan I).
Martin et al., J. Am. Chem. Soc., 103, 6237-6240 (1981).
Kitano et al., J. Org. Chem., 54, 994-996 (1989).
Pitchen et al., J. Am. Chem. Soc., 106, 8188-8193 (1984).
Di Furia et al., Synthesis, 1984, 325-326 (1984).
Kagen et al., Pure & Appl. Chem., 57(12), 1911-1916 (1985) (Kagen II).
Dunach et al., Nouv. J. Chim., 9(1), 1-3 (1985).
Brunner, Synthesis, 1988, 649 (1988).
Takata et al., Tet. Lett., 27(14), 1591-1594 (1986).
Kagan et al., Chemica Scripta, 25, 101-103 (1985) (Kagan III).
Kagan et al., Phosphorus and Sulfur, 27, 127-132 (1986) (Kagan IV).
Zhao et al., Tetrahedron, 43(21), 5135-5144 (1987) (Zhao I).
Beckwith et al., J. Chem Soc., Chem. Comm., 189-190 (1986).
Zhao et al., C.R. Acad. Sc. Paris, t. 304, II(7), 273-274 (1987) (Zhao II).
Gidda Jaswant S.
Panetta Jill A.
Phillips Michael L.
Eli Lilly and Company
Taylor Douglas J.
Tsang Cecilia
Whitaker Leroy
LandOfFree
Method of treating inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating inflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814742